FDA approves Lupin’s generic skin cream

The Food and Drug Administration on Monday approved Lupin’s fluocinonide topical skin cream.

Advertisement

The topical solution is used to relieve skin conditions such as inflammation or itching.

Lupin’s skin cream represents a generic version of County Line Pharmaceuticals’ Fluocinonide topical solution. Last year, Fluocinonide generated $ 32.4 million in U.S. sales, according to March 2017 IMS Health data cited by Lupin.

More articles on supply chain:

Supply chain leaders worried about potential market entry of Amazon
Drug prices will jump nearly 8% for health systems in 2018: 3 report findings
10 most popular prescription drugs for 2017

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Rethinking Safety and Security in the Healthcare Environment

Thursday, July 23
1:00 PM - 2:00 PM CDT

Presenters: Jon Share, AxonDan Snyder, Advocate HealthKeith Hunter, Wellstar

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.